Were there any notable capital expenditures, acquisitions, or dispositions disclosed in the 10‑Q? | BRT (Aug 07, 2025) | Candlesense

Were there any notable capital expenditures, acquisitions, or dispositions disclosed in the 10‑Q?

Based on the information provided in the news release, no specific capital expenditures, acquisitions, or dispositions were highlighted in BRT Apartments Corp.’s Form 10‑Q filing for the quarter ended June 30 2025.

The press‑release simply announces that the company has filed its quarterly report and that the full financial statements and supplemental information are available on the investor‑relations website. It does not detail any of the following:

Item Mentioned in the news release?
Capital expenditures (e.g., property improvements, development projects, equipment purchases) No
Acquisitions (e.g., new properties, portfolios, businesses) No
Dispositions (e.g., sales or retirements of assets) No

What this means

  • The filing itself may contain such information, but the summary you have does not disclose it.
  • If you need to know whether BRT Apartments Corp. reported any notable capex, acquisitions, or dispositions for Q2 2025, you will need to review the actual Form 10‑Q (or the accompanying “Financials – Quarterly Results” section on the company’s investor‑relations website).

Suggested next steps

  1. Access the 10‑Q – Go to BRT Apartments Corp.’s investor‑relations portal and download the Form 10‑Q for the quarter ended June 30 2025.
  2. Search the filing – Look for sections titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A),” “Capital Expenditures,” “Acquisitions and Dispositions,” or similar headings.
  3. Review footnotes and schedules – Often, details about property purchases, sales, or major improvements are disclosed in footnotes to the consolidated financial statements.

Until those documents are examined, the public announcement does not indicate any notable capital spending, acquisitions, or disposals for the period.